In late 2022, it is anticipated that Arkansas will begin to receive approximately $216 million as part of a national opioid settlement with an opioid manufacturer and three distributors. Our new white paper urges the adoption by states and localities of spending principles that have been endorsed by numerous medical, public health, academic, and advocacy organizations to help guide state and local spending of the settlement funds.